SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-200398
Filing Date
2011-07-28
Accepted
2011-07-28 13:04:09
Documents
12
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 626162
2 RESTRICTED STOCK AWARD AGREEMENT dex104.htm EX-10.4 29882
3 LETTER REGARDING UNAUDITED INTERIM FINANCIAL INFORMATION dex15.htm EX-15 2331
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 dex311.htm EX-31.1 7447
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 dex312.htm EX-31.2 7791
6 CERTIFICATION OF CEO AND CFO PURSUANT TO SECTION 906 dex32.htm EX-32 7226
  Complete submission text file 0001193125-11-200398.txt   2086308

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ctic-20110630.xml EX-101.INS 203185
8 XBRL TAXONOMY EXTENSION SCHEMA ctic-20110630.xsd EX-101.SCH 17041
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctic-20110630_cal.xml EX-101.CAL 36145
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctic-20110630_def.xml EX-101.DEF 87097
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctic-20110630_lab.xml EX-101.LAB 97008
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctic-20110630_pre.xml EX-101.PRE 93864
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062827100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12465 | Film No.: 11992720
SIC: 2834 Pharmaceutical Preparations